Skin donors positive for HBV core antibodies - To bank or not to bank? An overview from a regional tissue bank

Cell and Tissue Banking

Volumn 2, Issue 4, 2001, Pages 249-254

  Grossman, Nili ^a   Arbel, Edna ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

HBV; Organ and tissue donation; Serological testing; Skin; Tissue banking

Indexed keywords

HEPATITIS B CORE ANTIBODY;

ALGORITHM; ARTICLE; BRAIN DEATH; COMMUNICABLE DISEASE; CONTROLLED STUDY; HEALTH CARE FACILITY; HEPATITIS B; HUMAN; HUMAN TISSUE; INFORMED CONSENT; MEDICAL DECISION MAKING; ORGAN DONOR; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY CONTROL; SAFETY; SERODIAGNOSIS; SKIN GRAFT; STANDARD; VIRUS DETECTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0035783134     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021175512593     Document Type: Article

References (28)

1. American Association of Tissue Banks (1998) Standards for Tissue Banking. RG Kagan RG (ed) McLean, Virginia
2. Andre F (2000) Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 18(Suppl 1): S20-S22
3. Ben Bassat H, Strauss N, Ron M, Chaouat M, Breiterman S, Israeli A, Wexler MR and Eldad A (1996) Transplantation performance of human skin cryopreserved by programmed or stepwise freezing and store at -80°C or -180°C. J Burn Care Rehabil 17: 421-428
4. Ben Bassat H, Chaouat M, Zumai E, Segal N, Ron M, Wexler MR and Eldad A (2001) The Israel national skin bank: Quality assurance and graft performance of stored tissues. Cell and Tissue Banking 1: 303-312
5. Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rakela J and Fung JJ (1999) Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 69: 1058-1061
6. Dodson SF (2000) Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors. Clin Transplant 14(Suppl 2): 20-24
7. Eastlund T (1995) Infectious disease transmission through cell, tissue, and organ transplantation: Reducing the risk through donor selection. Cell Transplant 4: 455-477
8. European Association of Tissue Banks. Standards for Skin Banking and Banking Skin Substitutes (1997)
9. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S, Hess G, Hudig H, Kitchen A, Margolis H, Michel G, Trep C, Will H, Zanetti A and Mushahawar I (2000) Serological pattern 'anti-HBc alone': Report on a workshop. J Med Virol 62: 450-455
10. Hansbrough JF and Franco ES (1998) Skin replacements. Clinics in Plastic Surg 25: 407-423
11. Heim A, Wagner D, Rothamel T, Hartmann U, Flik J and Verhagen W (1999) Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation. J Med Virol 58: 291-295
12. Jongerius JM, Wester M, Cuypers HT, van Oostendorp WR, Lelie PN, van der Poel CL and van Leeuwen EF (1998) New hepatitis B virus mutant form in blood donor that is undectable in several hepatitis B surface antigen screening assays. Transfusion 38: 56-59
13. Kagan RG (2000) FDA regulation of human tissue: Implication for skin banks and burn centers. J Burn Care Rehabil 21: 353-357
14. Kawai H and Feinstone SM (2000) Acute viral hepatitis. In: Mandell GL, Bennett JE and Dolin R (eds) Principles of Practice of Infectious Diseases. pp 1279-1297. Churchill Livingstone, Philadelphia, PA
15. Ko W, Chou N, Hsu R, Chen Y, Wang S, Chu S and Lai M (2001) Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area. J Heart Lung Transplant 20: 865-875
16. Lowel JA, Howard TK, White HM, Shenoy S, Huettner PC, Brennan DC and Peters MG (1995) Serological evidence of past hepatitis B infection in liver donor and hepatitis B injection in liver allograft. Lancet 345: 1084-1085
17. Mackie DP (1997) The Euro Skin Bank: Development and application of glycerol - preserved allografts. J Burn Care Rehabil 18: 7-9
18. Madayag RM, Johnson LB, Bartlett ST, Schweitzer EJ, Constantini NT, McCarter RJ Jr, Kuo PC, Keay S and Oldach DW (1997) Use of real allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. Transplantation 64: 1781-1786.
19. Mason A, Wick M, White H and Perillo R (1993) Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology 18: 781-789
20. Nishiyori A, Fukuda K, Sata M and Tanikawa K (2000) HBV DNA can be detected from nail clippings of HBs Ag positive patients. Kurume Med J 47: 95-96
21. Robinson WS (2000) Hepatitis B virus and Hepatitis D virus. In: Mandell GL, Bennett JE and Dolin R (eds) Principles of Practice of Infectious Diseases. pp 1652-1685. Churchill Livingstone, Philadelphia, PA
22. Shaw-Stiffel TA (2000) Chronic hepatitis. In: Mandell GE, Bennett JE and Dolin R (eds) Principles of Practice of Infectious Diseases. pp 1297-1331. Churchill Livingstone, Philadelphia, PA
23. Sheridan RL and Tompkins RG (1999) Skin substitutes in burns. Burns 25: 97-103
24. Singer AJ and Clark RAF (1999) Cutaneous wound healing. N Engl J Med 341: 738-746
25. Tedder RS, Zuckerman MA, Goldstone AH, Hawkins AE, Fielding A, Briggs EM, Iewin Dm Blair S, Gorman AM, Patterson KG, Linch DC, Heptonstall J and Brink NS (1995) Hepatitis B transmission from contaminated cryopreservation tank. Lancet 346: 137-140
26. Tur-Kaspa R, Braun M and Ben-Ari Z (2002) Failure of reactivation of hepatitis B after liver transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients (commentary) Transplantation 73: 331-332
27. Uemoto S, Sugiyama K, Marusawa H, Inomata Y, Asonuma K, Egawa H, Kiuchi T, Miyaka Y, Tanaka K and Chiba T (1998) Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in liver related liver transplants. Transplantation 65: 494-499.
28. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Meltzer JS, Roberts JP, Tomlanovich SJ, Vincenti F et al. (1995) The risk of transmission of hepatitis B from HBsAg (-), HBcAb (+), HBIgM (-) organ donors. Transplantation 59: 230-234